ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Why pay $50 billion for the headache known as Tylenol? "
Episode Synopsis
Kimberly-Clark’s stock closed down 14% yesterday after it gambled nearly $50 billion on a company called Kenvue, maker of Listerine, Band-Aids, and Tylenol — the painkiller HHS Secretary Robert F. Kennedy wants to link to autism, despite a lack of scientific evidence. People are now suing Kenvue, a potential liability that will become Kimberly-Clark's problem. We unpack. Also: potential changes to public service loan forgiveness and a speech by Federal Reserve Governor Lisa Cook.
More episodes of the podcast Marketplace All-in-One
Shopping through a K-shaped holiday season
05/12/2025
Spotify Wrapped, user data, and FOMO
05/12/2025
Netflix is buying Warner Bros. Discovery
05/12/2025
What's next for the Fed?
04/12/2025
Is the U.S. a gerontocracy?
04/12/2025
California wine grapes rot on the vine
04/12/2025
Not REAL ID-compliant? Get ready to pay up.
04/12/2025
In God we trust